PlainRecalls
FDA Drug Low Class III Ongoing

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60

Reported: March 13, 2024 Initiated: February 20, 2024 #D-0365-2024

Product Description

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60

Reason for Recall

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

Details

Units Affected
11,750 bottles
Distribution
Nationwide in the U.S. and Puerto Rico
Location
Mississauga

Frequently Asked Questions

What product was recalled?
Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, L5N 6R8, NDC 71428-0003-60. Recalled by Contract Pharmaceuticals Limited Canada. Units affected: 11,750 bottles.
Why was this product recalled?
Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 13, 2024. Severity: Low. Recall number: D-0365-2024.